The everis Global Health Sector Director argues, through a real case, that medicine in the 21st Century is practiced using 19th Century processes. He goes on to point out the difficulties that come with not using an electronic healthcare system that is safe, intelligent and interconnected; the consumerization of healthcare and the risks that can be avoided with the informatiization of the sector.
Wendy C. was born in the year 2000. At that time, computer chaos threatened because of the change of a digit. Nothing happened and now no-one remembers the first great global technological psychosis.
Wendy was born in Chile and was a strong, healthy baby. Like any other child, she got the flu in winter, and this accentuated problems with asthma and pollution in Santiago, the Chilean capital. She was thus taken to the emergency room twice at the modern clinics in the city.
The Vice-Rector of the H.A. Barceló Foundation Health Sciences University Institute and the Director of Incubando Salud writes about his experience as a participant of the FutureMed program at Singularity University on the NASA campus in Silicon Valley.
By Axel Barceló
Silicon Valley is renowned across the world as a mecca for technological innovation. In February, I had the opportunity to go there to take part in the FutureMed program at Singularity University (SU), an academic institution founded by Google, Cisco and other companies. Located on the NASA campus, its objective is to “gather, educate and inspire leaders, providing them with the tools to face humanity’s biggest challenges.” FutureMed is a personalized program that focuses on the cutting edge technologies that are going to revolutionize the practice of medicine and radically transform approaches to healthcare and the biomedical industry over the next decade.
Excited by what I was about to experience over the next 6 days, I received an unconventional welcome when I arrived at the SU campus: a robot greeted us and gave us our first instructions about the lodging, schedule and other relevant details. The first scheduled activity consisted of a tour of the NASA Research Park, one of the 10 centers run by the organization, where R&D activities have been carried out for more than 60 years to serve the objectives of the United States space program. Since 2002, the center has built links with academic, industrial and non-profit organizations to stimulate innovation and education in the scientific and research disciplines that are fundamental for space exploration, such as astrobiology, computing, biotechnology and nanotechnology.
In the afternoon, we attended a welcome talk given by Dr. Daniel Kraft, Executive Director of FutureMed. This young inventor, businessman and medical-scientific innovator from Stanford and Harvard, gave a quick rundown of the scheduled activities and an introduction to the technologies to which we were going to be exposed over the next few days, which included artificial intelligence, robotics, mobile health, 3D Printing, nanomedicine and genomics. This is the third consecutive year that the program has taken place and of the over 500 applications received, 90 participants were selected from over 35 countries. All of them had an excellent academic record and successful professional careers, representing a perfect opportunity to create a network of contacts and to hear some extremely interesting stories.
The author teaches Financial Behavior for the Master’s Course in Finance at the University of San Andrés and analyzes the success of biotechnological research companies that have had the best results so far.
During the dot com bubble, much fuss was also made about biotechnology companies associated with the mapping of the human genome. The main example at that time was Celera Genomics, which would later be acquired by Quest Diagnostics (DGX).
A question thus arises: are we faced once more with a speculative bubble surrounding biotechnology? Are there concrete advances and improvements or are we just discussing futuristic cures that are impossible to imagine in the here and now?
Reality starts with demonstrating palpable solutions. But most importantly of all the market confirms with its prices that the sector is changing in a revolutionary manner. The index of share prices of biotechnology companies, the Amex Biotech Index (BTK) is currently at a historical high.The index has risen 24% so far this year, making it one of the highest risers of the year, if we disregard volatile and leveraged products.
Based on a study by the Organization for Economic Development and Cooperation (OEDC), a technology expert analyzes the opportunities that ICTs offer in improving healthcare in the country.
By Rafael Orduz, Executive Director of Corporación Colombia Digital
The health of the population is one of the most important indicators that demonstrates the level of economic and social development of a country.
Among the World Bank’s World Development Indicators there are many different indicators related to the health of a nation’s population. Beginning with ‘life expectancy at birth’, which reflects how long an average citizen can expect to live in a certain country. This depends on multiple factors: the healthcare system and coverage, education, the level of political harmony (the presence or otherwise of armed conflicts), the influence of organized crime and, of course, per capita income.
In this context, the differences between countries are dramatic. While Japan, the third largest economy in the world, has a life expectancy at birth of 83 years, there are sub-Saharan and Asian (in this case Afghanistan) countries in which the figure is less than 50 years. In Colombia, according to the World Bank, life expectancy at birth is 73 years, a figure that places the country at a level that might be called ‘upper middle class’ in the society of nations.
Each one of these steps contains critical questions that should be asked during the process that will help you to make the best decision for your business.
By Vinicíus V. Guedes
Commercial and Marketing Manager at TDSA Systems.
This guide presents a decision-making process to help you to select the best software for your office, clinic or hospital. Each of the following steps contains critical questions that should be asked during the process: